Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.

MLA

Benkeser, David, et al. “Immune Correlates Analysis of a Phase 3 Trial of the AZD1222 (ChAdOx1 NCoV-19) Vaccine.” NPJ Vaccines, vol. 8, no. 1, Mar. 2023, p. 36. EBSCOhost, https://doi.org/10.1038/s41541-023-00630-0.

APA

Benkeser, D., Fong, Y., Janes, H. E., Kelly, E. J., Hirsch, I., Sproule, S., Stanley, A. M., Maaske, J., Villafana, T., Houchens, C. R., Martins, K., Jayashankar, L., Castellino, F., Ayala, V., Petropoulos, C. J., Leith, A., Haugaard, D., Webb, B., Lu, Y., … Gilbert, P. B. (2023). Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine. NPJ Vaccines, 8(1), 36. https://doi.org/10.1038/s41541-023-00630-0

Chicago

Benkeser, David, Youyi Fong, Holly E Janes, Elizabeth J Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, et al. 2023. “Immune Correlates Analysis of a Phase 3 Trial of the AZD1222 (ChAdOx1 NCoV-19) Vaccine.” NPJ Vaccines 8 (1): 36. doi:10.1038/s41541-023-00630-0.